Insider trade

Director received an award of 34K GDRX shares

Traded Nov 2, 2025 · Filed Nov 4, 2025

Goodrx HoldingsGDRX

34K
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 2, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 4, 2025

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001809519-25-000138
Filed / recorded

Nov 4, 2025, 12:59 AM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Trevor Bezdek

Relationship

Director

Security

Class A Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 2, 2025

Transaction code

A

Shares / units

33,530

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

160,082

Ownership form

Direct

Amendment

No

Footnotes from the filing

Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 3, 2026 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.